Zobrazeno 1 - 10
of 155
pro vyhledávání: '"Anand, Swaminath"'
Autor:
Fiorella Di Pastena, Gregory Pond, Evangelia E. Tsakiridis, Andre Gouveia, Elham Ahmadi, Olga-Demetra Biziotis, Amr Ali, Anand Swaminath, Gordon Okawara, Peter M. Ellis, Bassam Abdulkarim, Naseer Ahmed, Andrew Robinson, Wilson Roa, Mario Valdes, Peter Kavsak, Marcin Wierzbicki, James Wright, Gregory Steinberg, Theodoros Tsakiridis
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-9 (2024)
Abstract Introduction Growth differentiation factor 15 (GDF15) is a cytokine of the TGFβ family. Here, we analyzed GDF15 levels in patients with locally advanced non-small cell lung cancer (LA-NSCLC) who participated in OCOG-ALMERA (NCT02115464), a
Externí odkaz:
https://doaj.org/article/8cdf62e782fd48eb9e23a13a2e40ddfb
Autor:
Michael Bonert, Jens Schittenhelm, Housne Begum, Jian-Qiang Lu, Anand Swaminath, Rosalyn A Juergens, Alison Berzins, Jean-Claude Cutz, Asghar H Naqvi
Publikováno v:
PLoS ONE, Vol 19, Iss 11, p e0314205 (2024)
Brain metastases are frequent in neuropathology practices; however, the literature on their distribution is frequently derived from imaging studies. This work examined metastases of lung cancer to the brain through the lens of pathology specimens. Al
Externí odkaz:
https://doaj.org/article/571b5ce1b48f40a1be3150f13a5a680f
Autor:
Alexander Piening, Anand Swaminath, John Dombrowski, Ryan M. Teague, Noor Al-Hammadi, Jeevin Shahi
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionFirst-line systemic therapy (ST) options for advanced hepatocellular carcinoma (HCC) include tyrosine kinase inhibitors and immunotherapy (IO). Evolving data suggest prolonged overall survival (OS) when ST is combined with stereotactic bo
Externí odkaz:
https://doaj.org/article/31aa5a5a81904032ae256bb391f596ce
Autor:
Anand Swaminath, Marcin Wierzbicki, Sameer Parpia, Vijayananda Kundapur, Sergio Faria, Naseer Ahmed, Alexis Bujold, Khalid Hirmiz, Timothy Owen, Nelson Leong, Kevin Ramchandar, Edith Filion, Harold Lau, Robert Thompson, Brian Yaremko, Zsolt Gabos, Selma Mehiri, James R. Wright, Theodoros K. Tsakiridis, Kathryn Cline, Timothy J. Whelan
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 37, Iss , Pp 145-152 (2022)
Purpose: To report on the Stereotactic Body Radiation Therapy (SBRT) credentialing experience during the Phase III Ontario Clinical Oncology Group (OCOG) LUSTRE trial for stage I non-small cell lung cancer. Methods: Three credentialing requirements w
Externí odkaz:
https://doaj.org/article/0dfb58d755984234bc52727ca70b9654
Autor:
Craig A. Beers, Gregory R. Pond, James R. Wright, Theodoros Tsakiridis, Gordon S. Okawara, Anand Swaminath
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposeFluoro-2-deoxyglucose positron-emission tomography (FDG-PET/CT) is now considered a standard investigation for the staging of new cases of stage III NSCLC. However, there is not published level 3 evidence demonstrating the impact of FDG-PET/CT
Externí odkaz:
https://doaj.org/article/8fcea20f776c4ae7ad659453e8722111
Autor:
Michael Bonert, Alison Berzins, Housne Begum, Jens Schittenhelm, Jian-Qiang Lu, Rosalyn A Juergens, Anand Swaminath, Jean-Claude Cutz, Asghar H Naqvi
Publikováno v:
PLoS ONE, Vol 18, Iss 11, p e0294154 (2023)
Brain metastases are a frequent occurrence in neuropathology practices. The literature on their neuroanatomical location is frequently derived from radiological analyses. This work examines brain metastases through the lens of pathology specimens. Al
Externí odkaz:
https://doaj.org/article/132ac9dd2caf4602bd91cda7dc0b4d7c
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-6 (2021)
Abstract Background Stereotactic Body Radiotherapy (SBRT) has shown effectiveness in treating bone metastases to alleviate pain. The benefit of SBRT may be further harnessed especially when radiating disease from primary malignancies with low alpha
Externí odkaz:
https://doaj.org/article/1849db8c4d60466388eb4108c4b7dc17
Publikováno v:
Current Oncology, Vol 28, Iss 4, Pp 2778-2788 (2021)
Introduction: Treatment algorithms for small cell lung cancer (SCLC) are determined largely by the Veterans Affairs Lung Cancer Staging Group (VALCSG) staging (limited (LS) versus extensive (ES) stage). Relapse occurs frequently; however, patterns of
Externí odkaz:
https://doaj.org/article/1c290a2ebadc423cb5018d287091d06a
Autor:
Charlotte Lynch BSc, MSc, Samantha Harrison BSc, MSc, John Butler MRCOG, MBBS, BSc, David R. Baldwin MA, DM, FRCPsych, FRSA, FHEA, Paul Dawkins MB ChB, MRCP, CCT Resp Med and Gen (Int) Med, FRCP 2012, FRACP, Joris van der Horst MD, FRCP, Erik Jakobsen MD, MPM, Jonathan McAleese MD, Annette McWilliams MBBS, Karen Redmond MB BCh NUI, Anand Swaminath MD, MSc, FRCPC, Christian J. Finley MD, MPH
Publikováno v:
Cancer Control, Vol 29 (2022)
Background Research from the International Cancer Benchmarking Partnership (ICBP) demonstrates that international variation in lung cancer survival persists, particularly within early stage disease. There is a lack of international consensus on the c
Externí odkaz:
https://doaj.org/article/8e456908d8844a9582a9f7189fcaf356
Autor:
Eric K. Nguyen, MD, Aly Khan A. Lalani, MD, Sunita Ghosh, PhD, PStat, Naveen S. Basappa, MD, Anil Kapoor, MD, Aaron R. Hansen, MD, Christian Kollmannsberger, MD, Daniel Heng, MD, MPH, Lori A. Wood, MD, MSc, Vincent Castonguay, MD, Denis Soulières, MD, MSc, Eric Winquist, MD, MSc, Christina Canil, MD, Jeffrey Graham, MD, Georg A. Bjarnason, MD, Rodney H. Breau, MD, MSc, Frédéric Pouliot, MD, PhD, Anand Swaminath, MD, MSc
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 4, Pp 100899- (2022)
Purpose: With the integration of immunotherapy (IO) agents in the management of metastatic renal cell carcinoma (mRCC), there has been interest in the combined use with radiation therapy (RT). However, real world data are limited. The purpose of this
Externí odkaz:
https://doaj.org/article/43f035c672774db193ffcf1e0e1b7f1a